The study examined an intervention’s efficacy at a community hospital in Norway. The intervention was a bundle that included a flow chart for sepsis identification, treatment and physician response time, a systemic inflammatory response syndrome and organ failure triage that was used to re-evaluate for sepsis if clinically indicated.
Researchers examined 472 patients with confirmed bloodstream infection before the intervention was put into place — the pre-intervention group. They examined 409 patients with confirmed bloodstream infection after the intervention was implemented — the post-intervention group.
The study found that the post-intervention group were observed more closely by nurses and had higher odds of surviving 30 days. The post-intervention group also had lower probability of developing severe organ failure and a shorter length-of-stay — shorter by 3.7 days on average.
More articles on quality:
States’ progress in reducing SSIs from colon surgery
Medical errors up 60% in Massachusetts as Baystate dialysis unit encounters problems
Hospitals with high patient experience star ratings don’t have better outcomes, new analysis finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
